The 9th Venous Conference (VC 2025), also known as the "9th Venous Conference and 25th Symposium on New Technologies for Peripheral Vascular Disease Intervention", is a professional conference hosted by the Beijing Health Promotion Association and guided by multiple authoritative academic institutions such as the China Venous Intervention Alliance. The conference will be held grandly at the Jiangsu Provincial Convention Center from September 5th to 7th, 2025. At the 9th Venous Conference (VC 2025), Ensheng Medical showcased its core product V-Mixtent ® Venous stent system and V-CLOFF ® The deep vein thrombosis clearance system, consisting of two products, has attracted the attention of numerous attending experts as a "dual star" solution for venous therapy. Ensheng Medical's V-Mixtent ® The venous stent adopts a unique modular hybrid design of "carving+weaving". Its proximal end

As an authoritative academic platform in the field of vascular surgery in the Asia Pacific region, APAC has gathered numerous top experts from home and abroad for in-depth exchanges and discussions on the latest research and clinical progress in the diagnosis and treatment of vascular diseases. Ensheng Medical made its debut at this conference and specially invited Dr. Raden Suhartono, a renowned Indonesian vascular surgeon (hereinafter referred to as Dr. Tono), to showcase V-Mixtent together ® The innovative breakthrough of the venous stent system presents the excellent performance of this Chinese made venous stent in the treatment of venous obstructive diseases. Ensheng Medical invited Dr. Tono to give a technical presentation at the conference. Dr. Tono's speech focused on the current situation of venous disease management in Indonesia, detailing the country's progress and challenges in the treatment of venous diseases. Indonesia in the treatment of venous diseases

Congratulations to Ensheng Medical for successfully being selected as a representative product case in the "China High Quality Medical Device Overseas Selection Guidelines (2025)" and joining hands to embark on a new journey in global healthcare! Ensheng EndoVas, Shanghai, April 16, 2025 10:16. As the first official guiding publication in China focusing on medical device overseas, the "Overseas Selection Guidelines" are led by the Lingang New Area Medical Device Innovation Center, integrating government resources, industry data, and global networks, aiming to build a bridge for Chinese medical device enterprises to "go global". This guide systematically summarizes the current situation, overseas trends, and key products of China's medical device industry. It is released in both Chinese and English to the world, covering international exhibitions, medical institutions, and overseas markets. It is an important window for overseas customers to understand China's high-quality medical devic

The first EndoVas Ancient City Vascular Forum, hosted by the Shaanxi Geriatric Medical Association and organized by the Second Affiliated Hospital of Xi'an Jiaotong University, was grandly held on November 8-9, 2024 in the ancient city of Xi'an. The conference focused on hot academic topics such as lower limb veins, thoracic and abdominal aorta, and peripheral arteries, attracting hundreds of top experts and scholars in the field of vascular surgery. The Ensheng Medical booth attracted the attendance of many experts. Director Yuan Huijun of Xi'an Red Cross Hospital personally visited the scene and demonstrated V-Mixtent ® The release process of the sample holder. Director Yuan on V-Mixtent ® The modular design of the bracket has been highly praised, and it is believed that its innovative integrated carving and weaving design can effectively cope with it

Congratulations to Shanghai Ensheng Medical for winning the bid in the fifth batch of national consumables procurement! EndoVas December 19, 2024 12:05 Shanghai

Original Empowerment, International Recognition - Ensheng Medical Helps Xiangya Hospital, ESAL Prediction Tool is Released on March 24, 2025 at 19:37. As an innovative enterprise deeply rooted in the field of peripheral venous vessels, Shanghai Ensheng Medical has always been committed to transforming cutting-edge technology into clinical value, benefiting a wider range of clinical doctors and patients. Ji En Sheng Medical V-Mixtent ® After the clinical trial of the venous stent system was published in the international authoritative journal BMC Medicine, Professor Wang Wei's team from the Department of Vascular Surgery at Xiangya Hospital once again collaborated with Ensheng Medical to develop the ESAL prediction tool (etiology stenosis age lesion length classification model), which was heavily published in the international authoritative journal "Journal of Endovascular Therapy"! Thesis information: Research background and purpose: Iliac vein stenting (IVSP)